会社概要
PrimeVigilance（Ergomed Group傘下）は、2008年の設立以来、医薬品安全性（ファーマコヴィジランス）に特化した国際的なサービスプロバイダーとして、世界各地で事業を展開しています。
ヨーロッパ・北米・アジアにæ ç¹ãæ§ããã¡ãã£ã«ã«ã¤ã³ãã©ã¡ã¼ã·ã§ã³ããã¡ã¼ãã³ã´ã£ã¸ã©ã³ã¹ãè¬äºãå質ä¿è¨¼ã®é åã§é«å質ãªãµã¼ãã¹ãæä¾ãã¦ãã¾ããå½ç¤¾ã¯ã製è¬ä¼æ¥ããã³ãã¤ãªãã¯ããã¸ã¼ä¼æ¥ï¼å¤§æããä¸å°ãå«ãï¼ã«å¯¾ããé«å質ãªãµã¼ãã¹ãæä¾ããé·æçãªãã¼ããã¼ã·ãããç¯ãã¦ãã¾ãããå»çæ©å¨ãå«ãããããæ²»çé åãã«ãã¼ããæ¥çã«ãããã°ãã¼ãã«ãªã¼ãã¼ã®ä¸ç¤¾ã¨ãã¦ç¢ºããªå°ä½ãç¯ãã¦ãã¾ããã¾ãã社å¡ã®æé·ãæ¯ããç ä¿®ã»è²æãã©ãããã©ã¼ã ã¸ã®ç©æ¥µçãªæè³ãåããããç°å¢ã¥ãããã¯ã¼ã¯ã©ã¤ããã©ã³ã¹ã®éè¦ãéãã¦ãä¸äººã²ã¨ããæ大éã®ããã©ã¼ãã³ã¹ãçºæ®ã§ããç°å¢ãæ´ãã¦ãã¾ãã æ£è
æ§ã®çæ´»ãããè¯ãããããã®ãã®ããã·ã§ã³ã«ããã²å
±ã«åãçµã¿ã¾ãããã
è·åå 容
ï¼æå®ãããããã¸ã§ã¯ããã¾ãã¯è¤æ°ããã¸ã§ã¯ãã«ããã¦ãICSR 管çãæ å½ãããã¼ã ããªã¼ãããï¼ããã¸ã§ã¯ãã«ãããæ¥åã®é åãæé©åããã¯ã¼ã¯ããã¼å ¨ä½ãç£ç£ãã
ï¼ICSR 管çé åã«ãããã¯ã©ã¤ã¢ã³ãã¨ã®åæ»ãã¤å¹æçãªååä½å¶ãæ§ç¯ãã
主ãªå½¹å²ã»è²¬ä»»ï¼Role & Responsibilitiesï¼
å¿åè³æ ¼
å¿ é è¦ä»¶
ãã®ä»æ å ±
Why PrimeVigilance?
å½ç¤¾ã¯ã製è¬ä¼æ¥ããã³ãã¤ãªãã¯ããã¸ã¼ä¼æ¥ï¼å¤§æããä¸å°ãå«ãï¼ã«å¯¾ããé«å質ãªãµã¼ãã¹ãæä¾ããé·æçãªãã¼ããã¼ã·ãããç¯ãã¦ãã¾ãããå»çæ©å¨ãå«ãããããæ²»çé åãã«ãã¼ããæ¥çã«ãããã°ãã¼ãã«ãªã¼ãã¼ã®ä¸ç¤¾ã¨ãã¦ç¢ºããªå°ä½ãç¯ãã¦ãã¾ããã¾ãã社å¡ã®æé·ãæ¯ããç ä¿®ã»è²æãã©ãããã©ã¼ã ã¸ã®ç©æ¥µçãªæè³ãåããããç°å¢ã¥ãããã¯ã¼ã¯ã©ã¤ããã©ã³ã¹ã®éè¦ãéãã¦ãä¸äººã²ã¨ããæ大éã®ããã©ã¼ãã³ã¹ãçºæ®ã§ããç°å¢ãæ´ãã¦ãã¾ãã
æä¾å 容
å½ç¤¾ã®ã³ã¢ããªã¥ã¼ã¯ãPrimeVigilanceã®ã«ã«ãã£ã¼ã¨æ¥ã ã®æ¥åãæ¯ããåºç¤ã¨ãªã£ã¦ãã¾ãããããã®ä¾¡å¤è¦³ã«å ±æããã ããæ¹ã§ããã°ãPrimeVigilanceã¯ãã£ã¨çæ³çãªç°å¢ã¨ãªãã§ãããã
çæ§ã®ãå¿åãå¿ãããå¾ ã¡ãã¦ããã¾ãã
Established in 1997, Ergomed is a global leader in delivering specialized services in oncology, rare disease, and complex trials to the pharmaceutical and biotech sectors. Our comprehensive support covers the entire clinical trial process, from early phase to post-approval, offering full-service, industry-leading clinical trial management solutions as a trusted partner. Our integrated service model helps life sciences companies meet regulatory obligations, maximize drug development success, and enhance the patient experience.
